Levonorgestrel tabletas 1.5mg - Prices and coupons for 1 package (2 tablets) of levonorgestrel 0.75mg
Levonorgestrel mg Tablets mm mm Package leaflet: Information for the user Levonorgestrel mg tablets are not indicated for .
It should in no instance replace levonorgestrel regular contraceptive method. Emergency contraception does not prevent a pregnancy tabletas occur in every instance, especially 1.5mg uncertainty about the timing of the unprotected intercourse. In case of doubt menstrual periods delayed by more than five days or 1.5mg bleeding at the expected date of menstrual periods, levonorgestrel tabletas 1.5mg, symptoms of pregnancyit is mandatory to check the absence of tabletas by performing a pregnancy test.
If levonorgestrel woman has had unprotected intercourse more than 72 hours earlier in the same menstrual cycle, conception may have occurred.
LEVONORGESTREL 1.5MG TABLETS
Treatment with NorLevo following the second act of intercourse may therefore be ineffective in preventing pregnancy. Limited and inconclusive data suggest tabletas there may be reduced efficacy of NorLevo with increasing body weight or body mass index BMI see section 5. In all women, emergency contraception should be taken as 1.5mg as possible after unprotected intercourse, regardless of the woman's body weight or BMI, levonorgestrel tabletas 1.5mg.
If pregnancy occurs after treatment with NorLevo, the levonorgestrel of an ectopic pregnancy should be considered.
levonorgestrel The absolute risk of 1.5mg pregnancy is likely to be low as NorLevo prevents ovulation and fertilisation. Ectopic tabletas may continue, despite the occurrence of uterine bleeding.
USES OF UNWANTED-72 PILL
Therefore, levonorgestrel tabletas 1.5mg, NorLevo is not recommended for patients who are at risk of ectopic pregnancy previous history of salpingitis or of ectopic pregnancy. NorLevo is not recommended in patients with severe hepatic dysfunction.
DESCRIPTION
Severe malabsorption syndromes, such as Crohn's disease, might 1.5mg the efficacy of NorLevo. Cases of thromboembolic events have been reported after NorLevo intake. The possibility of occurrence of a thromboembolic event should be considered in women with other pre-existing thromboembolic risk factor sespecially personal or family history suggesting thrombophilia.
After NorLevo intake, menstrual periods are usually of normal abundance and occur at the expected date. They can sometimes occur earlier or later than expected by a few days. It is recommended to have a medical visit to initiate or adapt a method of regular contraception. In case no menstrual period occurs levonorgestrel the next pill-free period following the use of NorLevo after regular hormonal contraception, pregnancy should be ruled out.
Repeated administration within a menstrual cycle is not advisable, because of an undesirable high load of hormones for the patient and the possibility of severe disturbances of tabletas cycle. Women who present for repeated courses of emergency contraception should be advised to consider long-term methods of contraception. The use of emergency contraception does not replace the necessary precautions against sexually transmitted diseases.
Concomitant use of NorLevo and drugs containing ulipristal acetate is not recommended see section 4. This medicinal product contains lactose monohydrate, levonorgestrel tabletas 1.5mg. Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine.
Levonorgestrel Tablets(1.5mg)
The metabolism of levonorgestrel is enhanced by concomitant use of liver enzyme 1.5mg, mainly CYP3A4 enzyme inducers, levonorgestrel tabletas 1.5mg.
Drugs suspected of having similar capacity to reduce plasma levels of levonorgestrel include barbiturates including primidonephenytoin, carbamazepine, herbal medicines containing Hypericum perforatum St. John's Wortrifampicin, levonorgestrel, rifabutin, tabletas griseofulvin.
For women who have levonorgestrel enzyme-inducing drugs in the past 4 weeks and need emergency contraception, the use of non-hormonal emergency contraception i. Taking a double dose of levonorgestrel i. Medicines containing levonorgestrel may increase the risk of cyclosporin toxicity due to possible inhibition of cyclosporin metabolism. Ulipristal acetate is a progesterone receptor tabletas that may interact with the progestational activity of levonorgestrel.
1.5mg the concomitant use of levonorgestrel and drugs containing ulipristal acetate is not recommended.